At what enterprise value was ALERIS acquired in 2026?

You can find the full valuation details of ALERIS on mynth capital. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 13.4x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of ALERIS when it was acquired by MEHILÄINEN GROUP?

The exact EV/EBITDA multiple for ALERIS is available on mynth capital. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 13.4x. Join our community for free to access full valuation data and industry trends.

When was ALERIS acquired by MEHILÄINEN GROUP?

ALERIS was acquired by MEHILÄINEN GROUP in 2026.

What was the revenue of ALERIS at the time of the deal?

The revenue of ALERIS at the time of the deal is estimated to be in the range of 5b - 100b SEK. Register for free to access the full transaction report and exact valuation multiples.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the ALERIS acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the ALERIS deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.triton-partners.com/news/tritonagrees-sale-of-aleris-to-mehilainen

← DATABASE

Home Database Healthcare & PharmaALERIS

05/2026

ALERIS

Acquired by

MEHILÄINEN GROUP

SWEDEN Health Providers / Healthcare Facilities / Clinics / Hospitals REV 5b - 100b SEK

ALERIS acquired by MEHILÄINEN GROUP

SWEDEN Health Providers / Healthcare Facilities / Clinics / Hospitals REV 5b - 100b SEK

Context

Mehiläinen Group acquired 100% of Aleris Group from Triton Partners in a transformational pan-European healthcare transaction. The deal was structured via a definitive share purchase agreement that pooled institutional equity from Mehiläinen's financial sponsors, CVC Capital Partners and Hellman & Friedman, alongside tailored cross-border corporate debt facilities. While the exact financial terms of the purchase price remained undisclosed, the transaction successfully integrated Aleris into Mehiläinen’s international operations as a distinct, specialized care platform. Under the binding terms of the agreement, Aleris Group CEO Sofia Palmquist retains her operational leadership role to ensure regional business continuity alongside Mehiläinen Group CEO Janne-Olli Järvenpää. This acquisition immediately expands Mehiläinen’s Scandinavian footprint into Norway and Denmark while drastically scaling its existing Swedish Meliva brand, creating a combined healthcare powerhouse with 60,000 professionals across 1,500 locations positioned to deliver highly integrated, digitally powered outpatient care pathways across Europe.

ALERIS, which reported an EBITDA margin of LOGIN in 2025, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the Healthcare & Pharma sector (13.4x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Aleris Group is a premier Scandinavian healthcare provider specializing in high-quality elective surgery, outpatient mental health services, and medical diagnostics. Headquartered in Stockholm, Sweden, the company operates via a multi-payer economic model, serving roughly millions patient visits annually through public healthcare system allocations, private health insurance programs, and out-of-pocket direct payments. The organization runs a unified network of approximately +100 clinics and hospitals staffed by +5,000 specialized medical professionals across Sweden, Norway, and Denmark. Strategically, the firm acts as a dominant, high-equity clinical complement to publicly funded healthcare systems, utilizing advanced digital infrastructure to streamline outpatient care pathways.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (SEK)

Year

Rev

EBITDA

EBIT

2025

2024

Other operations with ALERIS

Date	Acquirer	Target	Country	Sector	Deal Context
07/2019	TRITON PARTNERS	ALERIS	SWEDEN	Health Providers	Triton Partners acquired a controlling majority stake in Aleris Group from Patricia Industries in a significant Nordic healthcare transaction. The deal was structured via a definitive share purchase agreement and funded primarily through equity drawn from the Triton Fund V, a flagship vehicle that finalized fundraising at €5 billion in January 2019. Under the binding terms of the carve-out agreement, the digital healthcare platform entity Doktor24 was explicitly excluded from the perimeter and remained under the ownership of Patricia Industries. The transaction immediately transitioned Aleris into Triton’s healthcare portfolio, providing the asset with substantial institutional backing and capital reserves to fund downstream digital infrastructure updates and target localized clinical bolt-on acquisitions.

REFERENCES

Revenue range: 5b - 100b SEK

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ALERIS by MEHILÄINEN GROUP are reserved for mynth community members. Register for free to unlock full data.

Authors: mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Acquirer: mehiläinen group